• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白与 Parkin 在铁毒性对 SH-SY5Y 细胞中的相互作用:帕金森病发病机制的意义。

Interaction of α-synuclein and Parkin in iron toxicity on SH-SY5Y cells: implications in the pathogenesis of Parkinson's disease.

机构信息

Department of Biochemistry, Institute of Post-Graduate Medical Education and Research (IPGMER), Kolkata, India.

Department of Geriatric Medicine, Institute of Medical Sciences (IMS), Banaras Hindu University (BHU), Varanasi, India.

出版信息

Biochem J. 2020 Mar 27;477(6):1109-1122. doi: 10.1042/BCJ20190676.

DOI:10.1042/BCJ20190676
PMID:32108853
Abstract

The toxicity of accumulated α-synuclein plays a key role in the neurodegeneration of Parkinson's disease (PD). This study has demonstrated that iron in varying concentrations (up to 400 µM) causes an increase in α-synuclein content in SH-SY5Y cells associated with mitochondrial depolarization, decreased cellular ATP content and loss of cell viability during incubation up to 96 h. Knocking-down α-synuclein expression prevents cytotoxic actions of iron, which can also be prevented by cyclosporine A (a blocker of mitochondrial permeability transition pore). These results indicate that iron cytotoxicity is mediated by α-synuclein acting on mitochondria. Likewise siRNA mediated knock-down of Parkin causes an accumulation of α-synuclein accompanied by mitochondrial dysfunction and cell death during 48 h incubation under basal conditions, but these changes are not further aggravated by co-incubation with iron (400 µM). We have also analyzed mitochondrial dysfunction and cell viability in SH-SY5Y cells under double knock-down (α-synuclein and Parkin concurrently) conditions during incubation for 48 h with or without iron. Our results tend to suggest that iron inactivates Parkin in SH-SY5Y cells and thereby inhibits the proteasomal degradation of α-synuclein, and the accumulated α-synuclein causes mitochondrial dysfunction and cell death. These results have implications in the pathogenesis of sporadic PD and also familial type with Parkin mutations.

摘要

α-突触核蛋白的毒性在帕金森病 (PD) 的神经退行性变中起关键作用。本研究表明,不同浓度的铁(高达 400μM)会导致 SH-SY5Y 细胞中α-突触核蛋白含量增加,与线粒体去极化、细胞内 ATP 含量减少和细胞活力丧失有关,孵育时间长达 96 小时。敲低α-突触核蛋白表达可防止铁的细胞毒性作用,而环孢菌素 A(线粒体通透性转换孔的阻断剂)也可防止铁的细胞毒性作用。这些结果表明,铁的细胞毒性是由作用于线粒体的α-突触核蛋白介导的。同样,在基础条件下孵育 48 小时时,Parkin 的 siRNA 介导敲低会导致α-突触核蛋白积累,伴随着线粒体功能障碍和细胞死亡,但在与铁(400μM)共孵育时,这些变化不会进一步加重。我们还分析了在铁存在或不存在的情况下,SH-SY5Y 细胞在双重敲低(α-突触核蛋白和 Parkin 同时敲低)条件下孵育 48 小时时的线粒体功能障碍和细胞活力。我们的结果表明,铁在 SH-SY5Y 细胞中使 Parkin 失活,从而抑制α-突触核蛋白的蛋白酶体降解,而积累的α-突触核蛋白导致线粒体功能障碍和细胞死亡。这些结果对散发性 PD 以及伴有 Parkin 突变的家族性 PD 的发病机制具有重要意义。

相似文献

1
Interaction of α-synuclein and Parkin in iron toxicity on SH-SY5Y cells: implications in the pathogenesis of Parkinson's disease.α-突触核蛋白与 Parkin 在铁毒性对 SH-SY5Y 细胞中的相互作用:帕金森病发病机制的意义。
Biochem J. 2020 Mar 27;477(6):1109-1122. doi: 10.1042/BCJ20190676.
2
Dopamine Cytotoxicity on SH-SY5Y Cells: Involvement of α-Synuclein and Relevance in the Neurodegeneration of Sporadic Parkinson's Disease.多巴胺对 SH-SY5Y 细胞的细胞毒性:α-突触核蛋白的参与及其与散发性帕金森病神经退行性变的关系。
Neurotox Res. 2019 May;35(4):898-907. doi: 10.1007/s12640-019-0001-0. Epub 2019 Feb 26.
3
α-Synuclein-induced mitochondrial dysfunction in isolated preparation and intact cells: implications in the pathogenesis of Parkinson's disease.α-突触核蛋白在分离制剂和完整细胞中诱导的线粒体功能障碍:对帕金森病发病机制的影响
J Neurochem. 2014 Dec;131(6):868-77. doi: 10.1111/jnc.12966. Epub 2014 Nov 18.
4
Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson's Disease Etiopathology.细胞外α-突触核蛋白寡聚体诱导 Parkin 的 S-亚硝基化:与散发性帕金森病病因发病学的相关性。
Mol Neurobiol. 2019 Jan;56(1):125-140. doi: 10.1007/s12035-018-1082-0. Epub 2018 Apr 21.
5
Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synuclein.罗氟普明可减轻α-突触核蛋白诱导的细胞毒性,并促进过表达A53T突变型α-突触核蛋白的SH-SY5Y细胞中帕金蛋白的线粒体转位。
Toxicol Appl Pharmacol. 2022 Feb 1;436:115859. doi: 10.1016/j.taap.2021.115859. Epub 2022 Jan 4.
6
Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease.Parkin 相互作用底物锌指蛋白 746 是帕金森病的病理性中介物。
Brain. 2019 Aug 1;142(8):2380-2401. doi: 10.1093/brain/awz172.
7
[Pathogenesis of Parkinson's disease: a common pathway between alpha-synuclein and parkin and the mechanism of Lewy bodies formation].[帕金森病的发病机制:α-突触核蛋白与帕金蛋白之间的共同通路及路易小体形成机制]
Rinsho Shinkeigaku. 2005 Nov;45(11):905-7.
8
Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.培美曲塞通过调节 PINK1/Parkin 通路减少 ARTS 介导的 XIAP 降解,从而改善体内和体外帕金森病模型中的 6-羟多巴胺毒性和α-突触核蛋白积聚。
Int J Mol Sci. 2021 Sep 23;22(19):10240. doi: 10.3390/ijms221910240.
9
Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T α-synuclein model of Parkinson's disease.p38MAPK 对帕金森病 A53T α-突触核蛋白突变模型中 Parkin 的丝氨酸 131 的磷酸化促进线粒体功能障碍和神经元死亡。
Cell Death Dis. 2018 Jun 13;9(6):700. doi: 10.1038/s41419-018-0722-7.
10
LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells.长链非编码 RNA SNHG1 通过靶向 miR-15b-5p 激活 SIAH1 促进人神经母细胞瘤 SH-SY5Y 细胞中的 α-突触核蛋白聚集和毒性。
Neurotoxicology. 2018 Sep;68:212-221. doi: 10.1016/j.neuro.2017.12.001. Epub 2017 Dec 5.

引用本文的文献

1
Dimethyl-2-oxoglutarate but not antioxidants prevents glucose hypometabolism induced neural cell death: implications in the pathogenesis and therapy of Alzheimer's disease.2-氧代戊二酸二甲酯而非抗氧化剂可预防葡萄糖代谢减退诱导的神经细胞死亡:对阿尔茨海默病发病机制及治疗的启示
Biochem Biophys Rep. 2025 Jul 12;43:102150. doi: 10.1016/j.bbrep.2025.102150. eCollection 2025 Sep.
2
Ferroptosis and Iron Homeostasis: Molecular Mechanisms and Neurodegenerative Disease Implications.铁死亡与铁稳态:分子机制及对神经退行性疾病的影响
Antioxidants (Basel). 2025 Apr 28;14(5):527. doi: 10.3390/antiox14050527.
3
Mitochondrial Hydrogen Peroxide Activates PTEN and Inactivates Akt Leading to Autophagy Inhibition-Dependent Cell Death in Neuronal Models of Parkinson's Disease.
线粒体过氧化氢激活 PTEN 并失活 Akt,导致帕金森病神经元模型中自噬抑制依赖性细胞死亡。
Mol Neurobiol. 2023 Jun;60(6):3345-3364. doi: 10.1007/s12035-023-03286-y. Epub 2023 Feb 28.
4
GLUT inhibitor WZB117 induces cytotoxicity with increased production of amyloid-beta peptide in SH-SY5Y cells preventable by beta-hydroxybutyrate: implications in Alzheimer's disease.葡萄糖转运蛋白抑制剂WZB117在SH-SY5Y细胞中诱导细胞毒性并增加β-淀粉样肽的产生,β-羟基丁酸可预防这种情况:对阿尔茨海默病的影响
Pharmacol Rep. 2023 Apr;75(2):482-489. doi: 10.1007/s43440-023-00466-4. Epub 2023 Feb 27.
5
α-Synuclein Toxicity in Is Enhanced by the Presence of Iron: Implications for Parkinson's Disease.铁的存在增强了α-突触核蛋白在[具体部位未提及]的毒性:对帕金森病的影响。
Antioxidants (Basel). 2023 Jan 24;12(2):261. doi: 10.3390/antiox12020261.
6
Nilotinib in Parkinson's disease: A systematic review and meta-analysis.尼洛替尼治疗帕金森病:一项系统评价与荟萃分析。
Front Aging Neurosci. 2022 Sep 29;14:996217. doi: 10.3389/fnagi.2022.996217. eCollection 2022.
7
Neuroprotective effects of kukoamine A on 6-OHDA-induced Parkinson's model through apoptosis and iron accumulation inhibition.苦可胺A通过抑制细胞凋亡和铁蓄积对6-羟基多巴胺诱导的帕金森病模型的神经保护作用。
Chin Herb Med. 2020 Dec 8;13(1):105-115. doi: 10.1016/j.chmed.2020.12.004. eCollection 2021 Jan.
8
Targeting Molecular Mediators of Ferroptosis and Oxidative Stress for Neurological Disorders.靶向神经退行性疾病中铁死亡和氧化应激的分子介质。
Oxid Med Cell Longev. 2022 Jul 22;2022:3999083. doi: 10.1155/2022/3999083. eCollection 2022.
9
Neuroprotective Potency of Neolignans in Cortex Against Brain Disorders.新木脂素对大脑皮层预防脑部疾病的神经保护作用。
Front Pharmacol. 2022 Jun 16;13:857449. doi: 10.3389/fphar.2022.857449. eCollection 2022.
10
ATP13A2 protects dopaminergic neurons in Parkinson's disease: from biology to pathology.ATP13A2在帕金森病中保护多巴胺能神经元:从生物学到病理学
J Biomed Res. 2022 Mar 28;36(2):98-108. doi: 10.7555/JBR.36.20220001.